Phase Ib/IIa Clinical Study of ACC017 Tablets

This study is testing a new HIV treatment called ACC017 in adults living with HIV-1 who have never been treated with antiretroviral medications before. The goal is to see how safe the drug is and how well it reduces the amount of virus in the blood. **You may be eligible if...** - You are between 18 and 65 years old - You have confirmed HIV-1 infection and have never taken any anti-HIV medications or vaccines - Your viral load is high (HIV RNA at least 5,000 copies per mL) - Your immune cell count (CD4+ T cells) is above 200 cells per microliter - Your weight is at least 40 kg and your BMI is in the normal-to-overweight range (18.5–29.9) **You may NOT be eligible if...** - You have recently been diagnosed with acute HIV infection or have an unstable AIDS-related illness - You used HIV prevention medications (PrEP or PEP) in the past month - You have uncontrolled high blood pressure, serious heart disease, or uncontrolled diabetes - You have a history of severe drug or food allergies - You have had major abdominal surgery affecting drug absorption Talk to your doctor to see if this trial is right for you.